Patent · US Active

Gene recombination exchange system for stable gene modification in human ES cells

US7947501B2 · kind B2 · utility

1Cited by
0References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 6, 2009
Grant dateMay 24, 2011
Priority date
Expiry dateApr 18, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A method of creating a human pluripotent transgenic stem cell, wherein heterologous DNA is inserted into specific “hot-spots” in the genome where stable and high gene expression may occur, is disclosed. In one embodiment, the method comprises the steps of: (a) selecting a pluripotent stem cell line, and (b) inserting heterologous DNA at an insertion site selected from the group consisting of insertion site one and insertion site two to form a transgenic cell line. In another embodiment, the heterologous DNA is an exchange cassette and the transgenic cell line formed is a master cell line.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.